Pediatrics in Texas

Spark Biomedical Inc is a Dallas-based medical device manufacturer specializing in wearable neurostimulation solutions for complex care scenarios. The company's flagship FDA-cleared product, Sparrow Ascent, utilizes Transcutaneous Auricular Neurostimulation (tAN®) technology to deliver non-invasive, targeted bioelectronic medicine. Primary clinical applications include opioid withdrawal relief and medication reduction, with the platform expanding into neurological health, pediatrics, hemostasis, and women's health. The company conducts clinical trials and collaborates with leading healthcare organizations including the Veterans Administration, Hazelden Betty Ford Foundation, and the National Institutes of Health to advance drug-free treatment options and improve patient outcomes.

NuSmile, LTD is a specialized dental manufacturer and education provider focused on pediatric dentistry. The company designs and manufactures pediatric dental crowns, including stainless steel (SSC), zirconia (ZR), and the newer ReVIVE™ line of 3D printed, FDA-registered ceramic-reinforced composite crowns. NuSmile also produces restorative and preventive materials such as NeoPUTTY for space maintenance applications. The company operates an extensive continuing education program, offering hands-on Restore Workshops in multiple US cities covering restorative techniques, pediatric crown preparation, space maintainers, bioceramics, and clinical skill development. NuSmile conducts specialized Tech Day workshops focusing on intraosseous anesthesia injection systems and digital scanning technology for pediatric dentists. The company markets to pediatric dental practices, dental schools, and residency programs throughout North America and internationally. ReVIVE crowns carry FDA registration, indicating regulatory compliance for dental devices. NuSmile actively engages with professional pediatric dental organizations and conferences, providing both product support and clinical education through recognized dental experts.

Footprint Medical Incorporated is a neonatal-focused medical device company specializing in peripherally inserted central catheter (PICC) insertion products and related neonatal interventional supplies. Based in San Antonio, Texas, the company manufactures and distributes products designed for critically ill neonates and infants in intensive care settings. Their product portfolio includes PICC insertion trays and accessories, umbilical catheters, urinary drainage systems, and enteral feeding solutions—all designed specifically for the unique anatomical and clinical requirements of premature and vulnerable newborns. The company markets its offerings as purpose-built neonatal solutions supporting vascular access, fluid management, and nutritional support in NICU environments. Footprint Medical operates a direct-to-hospital model supplemented by specialty distributor partnerships, allowing regional flexibility in market reach. The company emphasizes clinical training and education, offering PICC insertion training programs to nursing and clinical staff. Business operations center on a 5-day work week in San Antonio, with established distribution and customer support infrastructure. While specific regulatory credentials are not detailed on the accessible site pages, neonatal medical devices of this nature typically require FDA 510(k) clearance or equivalent regulatory approval. The company targets neonatal intensive care units and regional perinatal centers where specialized vascular access and feeding support are critical clinical requirements.

BioAlign Inc. develops patient-specific, growth-driven implant technology for the treatment of early-onset scoliosis (EOS) in pediatric patients. The company's core innovation addresses a significant clinical need: current standard-of-care scoliosis correction procedures carry a 30–50% complication rate requiring revision surgery. BioAlign's proprietary technology platform includes self-actuating growth rods, patient-specific distraction procedures, and growth data monitoring systems designed to enable physiologic spine growth while correcting deformity, thereby reducing revision surgery rates and improving long-term patient outcomes. The company targets the approximately 40,000 annual pediatric scoliosis correction surgeries performed in the United States, where 3 million children have been diagnosed with the condition. BioAlign's leadership team brings cumulative experience exceeding 100 years in spine implant product development, FDA regulatory approval, and commercialization across major spinal implant manufacturers. The company holds 16+ granted patents across 7 countries and is actively raising capital for commercialization. Products are designed for use by orthopedic and spine surgeons in hospital operating rooms and specialized spine surgery centers.

Berlin Heart Inc. is a US-based medical device manufacturer specializing in ventricular assist devices (VADs) for mechanical circulatory support in pediatric and adult populations. Founded in 2005 as the North American subsidiary of Berlin Heart GmbH, the company develops and markets innovative extracorporeal circulatory support systems designed to bridge pediatric and neonatal patients awaiting heart transplantation or to support recovery from acute heart failure. The flagship EXCOR® Pediatric system has demonstrated clinical reliability with use in over 2,300 pediatric patients worldwide and is FDA-approved for use across US implanting centers. Berlin Heart maintains strategic partnerships with leading cardiac centers throughout North America and provides comprehensive clinical support services including anticoagulation management, training, and outcomes documentation through the ACTION Network collaborative initiative.

Core Access Surgical Technologies (CAST) is a US-based global medical device manufacturer specializing in innovative tools for minimally invasive laparoscopic surgery. The company designs and distributes precision devices that enhance surgical access and visualization while reducing complications associated with peritoneal entry. CAST's flagship product, LevaLap™ 1.0, is a single-use, dome-shaped optically clear device designed for Veress needle introduction in laparoscopic procedures. It standardizes access technique, facilitates first-attempt success, eliminates the need for a second operator during access, and reduces operative time—addressing the leading causes of laparoscopic surgery complications. The company is physician-driven in its engineering approach and has an expanding product pipeline including variants for trocar introduction, bariatric surgery, smaller BMI patients, and neonatal/pediatric applications. CAST's mission centers on making laparoscopic surgery access safer, more efficient, and standardized across all operator skill levels.

International Biomedical Ltd. is a family-owned neonatal and perinatal medical device manufacturer headquartered in Austin, Texas, with operations since 1974. The company designs, manufactures, and distributes specialized infant care solutions for critical care environments including NICUs, labor & delivery units, and neonatal transport operations. International Biomedical is recognized as the largest U.S. manufacturer of infant transport incubators and operates with over 100 employees generating approximately $16.5 million in annual revenue. The product portfolio encompasses transport incubators (AirBorne), radiant warmers, therapeutic cooling systems (Tecotherm Neo), phototherapy equipment (BiliCocoon), video laryngoscopy systems (NeoView), non-invasive bilirubin assessment (BiliChek), infant positioning aids (Transportle), and developmental care solutions including sucrose-based comfort measures. The company recently acquired Ameda, Inc. to expand into maternal lactation support. International Biomedical serves hospital systems, neonatal transport programs, and perinatal care facilities globally with a commitment to evidence-based developmental care principles and clinical innovation.

AIOMEGA LLC is a Tyler, Texas-based medical device company founded by Dr. R.V. Ghuge, a board-certified sleep medicine physician and president of Sleep Medicine Institute of Texas. The company develops patented oral airway devices for the treatment of obstructive sleep apnea (OSA) and snoring in both adult and pediatric populations. AIOMEGA's flagship product line includes the AIO Breathe (FDA-cleared for mild-to-moderate OSA in adults and children), AIO Breathe MB, AIO Swift, AIO Grit, AIO Brut, and AIO Revive. These devices are positioned as non-invasive alternatives to CPAP therapy, marketed for both medical and sports applications. The company emphasizes unprecedented airflow improvement through their proprietary technology. Products are available through The PAP Store e-commerce platform. AIOMEGA holds FDA clearance for treatment of OSA and snoring. The company serves dentists, physicians, athletes, coaches, trainers, and employees through dedicated portals, indicating multi-stakeholder market positioning. Manufacturing and product details beyond FDA-cleared status are not disclosed on the public website.